Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes (1995)
- Autores:
- Autor USP: WAJCHENBERG, BERNARDO LEO - FM
- Unidade: FM
- Assunto: ENDOCRINOLOGIA
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: Diabete & Metabolisme
- Volume/Número/Paginação/Ano: v.21, n.4 , p.274-80, 1995
-
ABNT
SANTOS, R F et al. Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes. Diabete & Metabolisme, v. 21, n. 4 , p. 274-80, 1995Tradução . . Acesso em: 24 abr. 2024. -
APA
Santos, R. F., Nomizo, R., Wajchenberg, B. L., Reaven, G. M., & Azhar, S. (1995). Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes. Diabete & Metabolisme, 21( 4 ), 274-80. -
NLM
Santos RF, Nomizo R, Wajchenberg BL, Reaven GM, Azhar S. Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes. Diabete & Metabolisme. 1995 ;21( 4 ): 274-80.[citado 2024 abr. 24 ] -
Vancouver
Santos RF, Nomizo R, Wajchenberg BL, Reaven GM, Azhar S. Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes. Diabete & Metabolisme. 1995 ;21( 4 ): 274-80.[citado 2024 abr. 24 ] - Bone involvement in idiopathic hypercalciuria
- Macroangiopatias
- Adrenocortical involvement
- Contrast analysis for the evaluation of the circadian rhythms of plasma cortisol, androstenedione , and testosterone in normal men and the possible influence of meals
- Sequential studies of glucose tolerance and red blood cell insulin receptors in normal human pregnancy
- Atypical antiinsulin receptor antibodies in a patient with type b insulin resistance and scleroderma
- Critical analysis of the true precocious puberty treatment
- Updating the use of biguanide oral agents
- Comparacao de um metodo qualitativo de deteccao da microalbuminuria (microbumintest) com um metodo quantitativo (rie) na avaliacao da nefropatia diabetica
- Searching for restriction fragment length polymorphisms in congenital goiter with defective thyroglobulin
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
